Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB00056> ?p ?o ?g. }
Showing items 1 to 19 of
19
with 100 items per page.
- drugbank:DB00056 type drugbank_vocabulary:Drug assertion.
- drugbank:DB00056 label "Gemtuzumab ozogamicin [drugbank:DB00056]" assertion.
- drugbank:DB00056 seeAlso gemtuzumab.htm assertion.
- drugbank:DB00056 seeAlso gemtuzumab-ozogamicin.html assertion.
- drugbank:DB00056 seeAlso DB00056 assertion.
- drugbank:DB00056 description "Recombinant humanized IgG4, kappa antibody conjugated with a cytotoxic antitumor antibiotic, calicheamicin, isolated from fermentation of a bacterium, Micromonospora echinospora ssp. calichensis. The antibody portion of Mylotarg binds specifically to the CD33 antigen, The anti-CD33 hP67.6 antibody is produced by mammalian cell suspension culture using a myeloma NS0 cell line. Gemtuzumab ozogamicin (trade name Mylotarg) was withdrawn in 2010 when a clinical trial showed the drug increased patient death and exhibited no advantages over traditional cancer therapies." assertion.
- drugbank:DB00056 identifier "drugbank:DB00056" assertion.
- drugbank:DB00056 title "Gemtuzumab ozogamicin" assertion.
- drugbank:DB00056 drugbank_vocabulary:x-cas cas:220578-59-6 assertion.
- drugbank:DB00056 drugbank_vocabulary:drugbank-id "BIOD00077" assertion.
- drugbank:DB00056 drugbank_vocabulary:drugbank-id "BTD00077" assertion.
- drugbank:DB00056 drugbank_vocabulary:drugbank-id "DB00056" assertion.
- drugbank:DB00056 bio2rdf_vocabulary:x-identifiers.org DB00056 assertion.
- drugbank:DB00056 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB00056" assertion.
- drugbank:DB00056 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB00056 bio2rdf_vocabulary:identifier "DB00056" assertion.
- drugbank:DB00056 drugbank_vocabulary:x-wikipedia wikipedia:Gemtuzumab_ozogamicin assertion.
- drugbank:DB00056 drugbank_vocabulary:x-pharmgkb pharmgkb:PA164749431 assertion.
- drugbank:DB00056 drugbank_vocabulary:x-ndc ndc:0008-4510-01 assertion.